General considerations for bioequivalence studies with pharmacokinetic methods for anti-schizophrenic drugs / 中国临床药理学与治疗学

ABSTRACT

On account of the characteristics of anti-schizophrenic drugs, combined with the technical guidelines for bioequivalence studies of anti-schizophrenic generic drugs in different regulatory institutions at home and abroad, taking some drugs as examples, this paper discusses the key points to be considered in carrying out bioequivalence studies from the perspective of experimental design, so as to provide certain reference for the research and development and evaluation of related products.